Entacapone: new preparation. Comparative data are lacking.

  • Published 1999 in Prescrire international


(1) Entacapone, a catechol-O-methyltransferase inhibitor, is indicated, in combination with levodopa + a dopadecarboxylase inhibitor, for the treatment of parkinsonian patients who have motor fluctuations on levodopa therapy. (2) The clinical file contains only placebo-controlled trials. (3) The two main clinical trials involved patients with moderate… (More)


Cite this paper

@article{1999EntacaponeNP, title={Entacapone: new preparation. Comparative data are lacking.}, author={}, journal={Prescrire international}, year={1999}, volume={8 44}, pages={167-9} }